摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,6R)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one | 1381968-82-6

中文名称
——
中文别名
——
英文名称
(1R,6R)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one
英文别名
——
(1R,6R)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one化学式
CAS
1381968-82-6
化学式
C14H17NO3
mdl
——
分子量
247.294
InChiKey
LBVADHIGECSPML-ZKYQVNSYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    53.1
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1R,6R)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-oneOxone 、 sodium tetrahydroborate 、 sodium dihydrogenphosphate dihydrate乙二胺四乙酸碳酸氢钠 作用下, 以 四氢呋喃乙醇丙酮乙腈叔丁醇 为溶剂, 反应 48.25h, 生成 (1R,5R,6R)-5-hydroxy-5-(hydroxymethyl)-3-((S)-1-phenylethyl)-7-oxa-3-azabicyclo[4.1.0]heptan-4-one
    参考文献:
    名称:
    The use of sodium chlorite in the non-racemic synthesis of a potent inhibitor of glycolipid biosynthesis
    摘要:
    A facile and environmentally friendly synthesis of both enantiomers of a biologically important 1-N-iminosugar (azasugar) is presented. To this end, the use of a very cheap and non-toxic reagent, such as sodium chlorite, is featured in two key reactions. Additionally, a highly stereoselective epoxidation with dimethyloxirane (DMDO), and regioselective acid-catalyzed epoxide ring opening are also two environmentally friendly reactions that are employed in this synthesis. For all the above-mentioned, and also taking into account that protecting groups were not employed, we would like to present this synthetic route as an efficient approach for the development of environmental and sustainable syntheses of highly oxygenated biologically important compounds. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2015.08.054
  • 作为产物:
    描述:
    参考文献:
    名称:
    使用亚氯酸钠制备2,3-环氧乙烷的直接化学方法
    摘要:
    据报道,一种直接的方法是使用亚氯酸钠通过串联的C–H氧化/双键环氧化从叔烯丙胺制备2,3-环氧酰胺。显然,反应过程包括两个步骤:(i)用亚氯酸钠将起始烯丙胺烯丙基氧化为相应的不饱和烯丙基酰胺,然后(ii)由次氯酸根离子将烯丙基酰胺环氧化为2,3-环氧酰胺,形成通过还原亚氯酸钠就地还原。反应条件容许存在游离羟基和典型的官能团,例如TBS,芳基,烷基,烯丙基,乙酰基和苄基;然而,当基质中存在活化的芳环(例如芝麻酚)时,必须使用清除剂。
    DOI:
    10.1021/jo300542d
点击查看最新优质反应信息

文献信息

  • Direct Chemical Method for Preparing 2,3-Epoxyamides Using Sodium Chlorite
    作者:Lilia Fuentes、Urbano Osorio、Leticia Quintero、Herbert Höpfl、Nixache Vázquez-Cabrera、Fernando Sartillo-Piscil
    DOI:10.1021/jo300542d
    日期:2012.7.6
    mediated by hypochlorite ion, which is formed in situ by reduction of sodium chlorite. The reaction conditions tolerate the presence of free hydroxyl groups and typical functional groups such as TBS, aryl, alkyl, allyl, acetyl, and benzyl groups; however, when an activated aromatic ring (e.g., sesamol) is present in the substrate, the use of a scavenger is necessary.
    据报道,一种直接的方法是使用亚氯酸钠通过串联的C–H氧化/双键环氧化从叔烯丙胺制备2,3-环氧酰胺。显然,反应过程包括两个步骤:(i)用亚氯酸钠将起始烯丙胺烯丙基氧化为相应的不饱和烯丙基酰胺,然后(ii)由次氯酸根离子将烯丙基酰胺环氧化为2,3-环氧酰胺,形成通过还原亚氯酸钠就地还原。反应条件容许存在游离羟基和典型的官能团,例如TBS,芳基,烷基,烯丙基,乙酰基和苄基;然而,当基质中存在活化的芳环(例如芝麻酚)时,必须使用清除剂。
  • The use of sodium chlorite in the non-racemic synthesis of a potent inhibitor of glycolipid biosynthesis
    作者:Carlos G. Gómez-Fosado、Leticia Quintero、Lilia Fuentes、Fernando Sartillo-Piscil
    DOI:10.1016/j.tetlet.2015.08.054
    日期:2015.10
    A facile and environmentally friendly synthesis of both enantiomers of a biologically important 1-N-iminosugar (azasugar) is presented. To this end, the use of a very cheap and non-toxic reagent, such as sodium chlorite, is featured in two key reactions. Additionally, a highly stereoselective epoxidation with dimethyloxirane (DMDO), and regioselective acid-catalyzed epoxide ring opening are also two environmentally friendly reactions that are employed in this synthesis. For all the above-mentioned, and also taking into account that protecting groups were not employed, we would like to present this synthetic route as an efficient approach for the development of environmental and sustainable syntheses of highly oxygenated biologically important compounds. (C) 2015 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

7-亚乙基-环戊二烯并(b)环氧乙烷并(c)吡啶六氢衍生物. 4-甲基-3-氧杂-6-氮杂三环[3.2.0.02,4]庚烷-7-酮 3-氧杂-6-氮杂三环[3.2.2.02,4]壬烷(8CI,9CI) 3-氧杂-1-氮杂三环[5.2.0.02,4]壬烷 2-氧杂-6-氮杂三环[4.3.1.01,3]癸烷 (1S,2R,4S,5R)-3-氧杂-6-氮杂三环[3.2.1.02,4]辛烷-7-酮 (5R,7S,8R,8aR)-5-dodecyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one (2S,2R,4S,5R,6S)-(+)-2-{2-[2-[1,3]-dioxolan-2-yl-ethyl]-6-methyl-4,5-epoxy-3,6-dihydro-2H-pyridin-1-yl}-2-phenylethanol (5R,7R,8S,8aR)-5-ethyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one dihydroabikoviromycin (1R,6R)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6S)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1aR,6aS,7R,7aS)-7-(t-butyldimethylsilyloxy)tetrahydro-1aH-oxazolo[3,4-a]oxireno[2,3-d]pyridin-4(2H)-one 11-formyl-(1rN,2tH,4tH,6cN,7tH,9tH)-3,8-dioxa-11-aza-tetracyclo[4.4.1.02,4.07,9]undecane 7-Oxa-2-azabicyclo[4.1.0]heptane (1S,6S)-1-(hydroxymethyl)-3-[(1R)-2-hydroxy-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-1-(hydroxymethyl)-3-[(1R)-2-hydroxy-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-3-[(1R)-2-[tert-butyl(dimethyl)silyl]oxy-1-phenylethyl]-1-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6S)-3-[(1R)-2-[tert-butyl(dimethyl)silyl]oxy-1-phenylethyl]-1-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 3-Oxa-10-azatricyclo[4.3.1.0~2,4~]decane (3S,5R,6R,7R)-6-hydroxy-4,9-dioxa-1-azatricyclo[5.3.0.03,5]decan-10-one (1RS,2SR,4RS,5SR)-3-oxa-6-azatricyclo[3.2.1.02,4]octan-7-one (1S,6S)-1-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 3-(methanesulfonyl)-7-oxa-3-azabicyclo[4.1.0]heptane 3α,4α-epoxy-2-piperidone (+)-tedanalactam 5-amino-1,2-anhydro-5-deoxy-D-lyxono-1,4-lactame (1R,5S,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,5R,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6R)-4,4,6-trimethyl-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6S)-4,4,6-trimethyl-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-3-(cyclopropylmethyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-ethyl-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-(2-methylpropyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-(2-methoxyethyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-methyl-7-oxa-3-azabicyclo[4.1.0]heptane (1S,6S)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6S)-7-oxa-2-azabicyclo[4.1.0]heptane (1S,6R)-7-oxa-2-azabicyclo[4.1.0]heptane (1R,6R)-7-oxa-3-azabicyclo[4.1.0]heptane (1S,2S,4R,5S)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (2R,4S,7S)-3-oxa-1-azatricyclo[5.2.0.02,4]nonane (1S,2S,4S,5R)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1S,2S,4S,5S)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (2S,4R,7S)-3-oxa-1-azatricyclo[5.2.0.02,4]nonane (1R,6R)-1-methyl-3-propyl-7-oxa-3-azabicyclo[4.1.0]heptane (1S,2R,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1R,2S,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1S,2S,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1R,6S)-3-methyl-7-oxa-3-azabicyclo[4.1.0]heptane